ZELIRA THERAPEUTICS LTD.ZELIRA THERAPEUTICS LTD.ZELIRA THERAPEUTICS LTD.

ZELIRA THERAPEUTICS LTD.

No trades
See on Supercharts
Market capitalization
‪4.44 M‬EUR
−2.006EUR
‪−22.76 M‬EUR
‪59.09 K‬EUR
‪10.84 M‬
Beta (1Y)
0.55

About ZELIRA THERAPEUTICS LIMITED


CEO
Oludare Odumosu
Headquarters
Perth
Founded
2003
ISIN
AU000000ZLD1
FIGI
BBG000QXBBF5
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ZELIRA THERAPEUTICS LTD. stocks are traded under the ticker G1G.
G1G reached its all-time high on Apr 26, 2006 with the price of 12,833.282 EUR, and its all-time low was 0.162 EUR and was reached on Jun 28, 2024. View more price dynamics on G1G chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ZELIRA THERAPEUTICS LTD. financials in yearly and quarterly reports right on TradingView.
G1G net income for the last half-year is ‪−1.51 M‬ EUR, while the previous report showed ‪−21.05 M‬ EUR of net income which accounts for 92.81% change. Track more ZELIRA THERAPEUTICS LTD. financial stats to get the full picture.
No, G1G doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZELIRA THERAPEUTICS LTD. EBITDA is ‪−3.54 M‬ EUR, and current EBITDA margin is ‪−6.00 K‬%. See more stats in ZELIRA THERAPEUTICS LTD. financial statements.
Like other stocks, G1G shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZELIRA THERAPEUTICS LTD. stock right from TradingView charts — choose your broker and connect to your account.